US20130046361A1 - Moldable charger with shape-sensing means for an implantable pulse generator - Google Patents
Moldable charger with shape-sensing means for an implantable pulse generator Download PDFInfo
- Publication number
- US20130046361A1 US20130046361A1 US13/569,027 US201213569027A US2013046361A1 US 20130046361 A1 US20130046361 A1 US 20130046361A1 US 201213569027 A US201213569027 A US 201213569027A US 2013046361 A1 US2013046361 A1 US 2013046361A1
- Authority
- US
- United States
- Prior art keywords
- charging head
- shape
- patient
- coil
- charging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3787—Electrical supply from an external energy source
Definitions
- the present invention relates to external charging devices for implantable devices, and more particularly, to devices for transcutaneously recharging devices implanted within patients.
- Implantable stimulation devices are devices that generate and deliver electrical stimuli to body nerves and tissues for the therapy of various biological disorders, such as: pacemakers to treat cardiac arrhythmia; defibrillators to treat cardiac fibrillation; cochlear stimulators to treat deafness; retinal stimulators to treat blindness; muscle stimulators to produce coordinated limb movement; spinal cord stimulators to treat chronic pain; cortical and deep brain stimulators to treat motor and psychological disorders; and other neural stimulators to treat urinary incontinence, sleep apnea, shoulder sublaxation, etc.
- the present invention may find applicability in all such applications, although the description that follows will generally focus on the use of the invention within a spinal cord stimulation system, such as that disclosed in U.S. Pat. No. 6,516,227 (“the '227 patent”), issued Feb. 4, 2003 in the name of inventors Paul Meadows et al., which is incorporated herein by reference in its entirety.
- power and/or data can be supplied to an implanted medical device via an RF or electromagnetic link that couples power from an external (non-implanted) coil to an internal (implanted) coil.
- a suitable link e.g., an inductive link
- power and/or data can be continuously supplied to the implanted medical device from the worn or carried external device, thereby allowing the implanted medical device to perform its intended function.
- the battery can be recharged by transcutaneously coupling power from an external source to an implanted receiver that is connected to the battery.
- power can be coupled from an external source at radio frequencies using matching antennas, it is generally more efficient to employ an external transmission coil and an internal receiving coil which are inductively (electromagnetically) coupled to each other to transfer power at lower frequencies.
- the external transmission coil is energized with alternating current (AC), producing a varying magnetic flux that passes through the patient's skin and induces a corresponding AC voltage in the internal receiving coil.
- AC alternating current
- the voltage induced in the receiving coil may then be rectified and used to power the implanted device and/or to charge a battery or other charge storage device (e.g., an ultracapacitor), which in turn powers the implanted device.
- a battery or other charge storage device e.g., an ultracapacitor
- U.S. Pat. No. 4,082,097 discloses a system for charging a rechargeable battery in an implanted human tissue stimulator by means on an external power source.
- the patient would benefit from a convenient unobtrusive external charging device that transmits power transcutaneously to an implanted device, wherein such external charging device is not only small and lightweight, but is also readily conformable to the patient in close proximity to the implanted device.
- the device could be constructed such that it could be formed to any shape when needed, or the device could be constructed to be shaped in one particular form and then remain in that form for frequent use on the same area of the patient.
- the shape of the charging coil in the external charging device changes as the external charging device is shaped to conform to the patient, the characteristics of the charge from the charging coil may change, possibly negatively impacting the coupling factor of the external charging device and the IPG and thus the efficiency of the charging action.
- good coupling increase the power transferred from the external charger to the implantable pulse generator, it also minimizes heating in the implantable pulse generator. This in turn reduces the power requirements of the external charger, which reduces heating of the external charger and minimizes the smaller form factor of the external charger.
- maintaining good coupling may be achieved by monitoring any change in the shape of the coil and subsequently adjusting power requirements of the external charger.
- an external charger for an implantable medical device comprising a charging head that is selectively shapeable to conform to a surface of a patient.
- the external charger also comprises an alternating current (AC) charging coil housed in the body and configured for transcutaneously transmitting electrical energy to the implanted medical device, wherein the shape of the coil is changeable as the body is shaped.
- the external charger further comprises at least one sensor, such as a strain gauge, for determining the shape of the coil.
- the external charger further comprises a processor configured to adjust the charge of the coil in response to receiving signals from the sensor(s) regarding changes in the shape of the coil.
- a method of charging an implantable medical device with the external charger comprising placing the external charger on a surface of a patient in the general vicinity of the implantable device and transcutaneously transmitting energy from the coil to the implantable medical device.
- the external charger is shaped to conform to the surface of the patient and adhered to the patient.
- FIG. 1 is plan view of one embodiment of a spinal cord stimulation (SCS) system arranged in accordance with the present inventions;
- SCS spinal cord stimulation
- FIG. 2 is a plan view of the SCS system of FIG. 1 in use with a patient;
- FIG. 3 is a perspective view of an external charger used in the SCS system
- FIG. 4 is a block diagram of the internal components of one embodiment of an external charger and implantable pulse generator used in the SCS system of FIG. 1 ;
- FIGS. 5A and 5B are perspective views with cut-outs of one embodiment of a charging head used in the SCS system of FIG. 1 ;
- FIGS. 6A and 6B are perspective views with cut-outs of alternative embodiments of the charging head shown in FIGS. 5A and 5B ;
- FIGS. 7A and 7B are perspective views of another alternative embodiment of the charging head shown in FIGS. 5A and 5B ;
- FIGS. 8A and 8B are perspective views of another alternative embodiment of a charging head, featuring a curable material, used in the SCS system of FIG. 1 ;
- FIGS. 9A-9F are perspective views with cut-outs of another alternative embodiment of a charging head, featuring a plurality of hinged sections, used in the SCS system of FIG. 1 ;
- FIG. 10 is a perspective view of an alternative embodiment of the charging head shown in FIGS. 9A-9F ;
- FIG. 11 is a flow diagram of a method used by the external charger to charge the implantable pulse generator.
- FIGS. 12 and 13 are perspective views of a method of using the external charger in the SCS system of FIG. 1 , and in particular using the charging head illustrated in FIGS. 5A and 5B ;
- FIG. 14 is a perspective view of a method of using the external charger in the SCS system of FIG. 1 , and in particular using the charging head illustrated in FIGS. 8A-8F .
- the present invention may be used with an implantable pulse generator (IPG) or similar implanted electrical stimulator, which may be used as a component of numerous different types of stimulation systems.
- IPG implantable pulse generator
- SCS spinal cord stimulation
- the invention lends itself well to applications in SCS, the invention, in its broadest aspects, may not be so limited. Rather, the invention may be used with any type of implantable electrical circuitry used to stimulate tissue.
- the present invention may be used as part of a pacemaker, a defibrillator, a cochlear stimulator, a retinal stimulator, a stimulator configured to produce coordinated limb movement, a cortical and deep brain stimulator, peripheral nerve stimulator, or in any other neural stimulator configured to treat urinary incontinence, sleep apnea, shoulder sublaxation, etc.
- an exemplary SCS system 10 generally comprises an implantable neurostimulation lead 12 , an implantable pulse generator (IPG) 14 , an external (non-implanted) programmer 16 , and an external (non-implanted) charger 18 .
- the lead 12 is a percutaneous lead and, to that end, includes a plurality of in-line electrodes 20 carried on a flexible body 22 .
- the IPG 14 is electrically coupled to the lead 12 in order to direct electrical stimulation energy to each of the electrodes 20 .
- the IPG 14 includes an outer case formed from an electrically conductive, biocompatible material, such as titanium.
- the case forms a hermetically sealed compartment wherein the electronic and other components are protected from the body tissue and fluids. While a portion of the electronic components of the IPG 14 will be described in further detail below, additional details of the IPG 14 , including the battery, antenna coil, and telemetry and charging circuitry, are disclosed in U.S. Pat. No. 6,516,227, which is expressly incorporated herein by reference.
- the neurostimulation lead 12 is implanted within the epidural space 26 of a patient through the use of a percutaneous needle or other convention technique, so as to be in close proximity to the spinal cord 28 .
- the electrodes 20 may be used to supply stimulation energy to the spinal cord 28 or nerve roots.
- the preferred placement of the lead 12 is such that the electrodes 20 are adjacent, i.e., resting upon, the nerve area to be stimulated.
- the IPG 14 may be implanted in various suitable locations of the patient's body, such as in a surgically-made pocket either in the abdomen or above the buttocks.
- a lead extension 30 may facilitate locating the IPG 14 away from the exit point of the lead 12 .
- the IPG 14 is programmed, or controlled, through the use of the external programmer 16 .
- the external programmer 16 is transcutaneously coupled to the IPG 14 through a suitable communications link (represented by the arrow 32 ) that passes through the patient's skin 34 .
- Suitable links include, but are not limited to radio frequency (RF) links, inductive links, optical links, and magnetic links.
- RF radio frequency
- the electronic components of the external programmer 16 will not be described herein. Details of the external programmer, including the control circuitry, processing circuitry, and telemetry circuitry, are disclosed in U.S. Pat. No. 6,516,227, which has been previously incorporated herein by reference.
- the external charger 18 is transcutaneously coupled to the IPG 14 through a suitable link (represented by the arrow 36 ) that passes through the patient's skin 34 , thereby coupling power to the IPG 14 for the purpose of operating the IPG 14 or replenishing a power source, such as a rechargeable battery (e.g., a Lithium Ion battery), within the IPG 14 .
- a power source such as a rechargeable battery (e.g., a Lithium Ion battery)
- the link 36 is an inductive link; that is, energy from the external charger 18 is coupled to the battery within the IPG 14 via electromagnetic coupling.
- the IPG 14 may function as programmed without the external programmer 16 or the external charger 18 being present. While the external programmer 16 and external charger 18 are described herein as two separate and distinct units, it should be appreciated that the functionality of the external programmer 16 and external charger 18 can be combined into a single unit. It should be noted that rather than an IPG, the system 10 may alternatively utilize an implantable receiver-stimulator (not shown) connected to lead 12 .
- the power source e.g., a battery
- the power source for powering the implanted receiver, as well as control circuitry to command the receiver-stimulator, will be contained in an external controller/charger inductively coupled to the receiver-stimulator via an electromagnetic link.
- the external charger 18 takes the form of a two-part system comprising a portable charger 50 and a charging base station 52 .
- the charging base station 52 includes an AC plug 54 , so that it can be easily plugged into any standard 110 volt alternating current (VAC) or 200 VAC outlet.
- the charging base station 52 further includes an AC/DC transformer 55 , which provides a suitable DC voltage (e.g., 5 VDC) to the circuitry within the charging base station 52 .
- the portable charger 50 includes a housing 56 for containing circuitry, and in particular, the recharging circuitry and battery (not shown in FIG. 3 ), which will be discussed in further detail below.
- the housing 56 is shaped and designed in a manner that allows the portable charger 50 to be detachably inserted into the charging base station 52 and returned to the charging base station 52 between uses, thereby allowing the portable charger 50 , itself, to be recharged.
- both the IPG 14 and the portable charger 50 are rechargeable.
- the portable charger 50 may be returned to the charging base station 52 between uses.
- the portable charger 50 may be carried on the patient, e.g., in a pouch strapped to the patient, or placed near the patient.
- the portable charger 50 includes a charging head 58 connected to the housing 56 by way of a suitable flexible cable 60 .
- the charging head 58 is shown in this embodiment as having a curvaceous shape and is also flexible, more details of which will be provided below.
- the charging head 58 houses an antenna 82 , and in particular an AC coil 82 (see FIGS. 5A and 5B ), which will also be described in more detail below.
- the coil 82 transmits the charging energy to the IPG 14 .
- the portable charger 50 does not include a separate charging head, but instead includes a single housing that contains the recharging circuitry, battery, and AC coil.
- FIG. 4 the recharging elements of the IPG 14 and external charger 18 will now be described. It should be noted that the diagram of FIG. 4 is functional only, and is not intended to be limiting. Those of skill in the art, given the descriptions presented herein, should be able to readily fashion numerous types of recharging circuits, or equivalent circuits, that carry out the functions indicated and described.
- the portable charger 50 includes a battery 66 , which in the illustrated embodiment is a rechargeable battery, such as a Lithium Ion battery.
- a rechargeable battery such as a Lithium Ion battery.
- energy shown by arrow 68
- the battery 66 is fully charged in approximately four hours. Once the battery 66 is fully charged, it has enough energy to fully recharge the battery of the IPG 14 . If the portable charger 50 is not used and left on charger base station 52 , the battery 66 will self-discharge at a rate of about 10 % per month. Alternatively, the battery 66 may be a replaceable battery.
- the portable charger 50 also includes: a charge controller 70 , which serves to convert the DC power from an AC/DC transformer 55 to the proper charge current and voltage for the battery 66 ; a battery protection circuit 72 , which monitors the voltage and current of the battery 66 to ensure safe operation via operation of FET switches 74 , 76 ; a fuse 78 that disconnects the battery 66 in response to an excessive current condition that occurs over an extended period of time; a power amplifier 80 , and in particular a radio frequency (RF) amplifier, for converting the DC power from the battery 66 to a large alternating current; and an electrical current detector 108 that measures the magnitude of the electrical current input from the power amplifier 80 into the coil 82 , and continually outputs the measured magnitudes to a processor 120 as the frequency of the current is varied. Further details discussing this control and protection circuitry are described in U.S. Pat. No. 6,516,227, which has been previously incorporated herein by reference.
- the charging head 58 is flexible so as to be selectively shaped to conform to a patient.
- the coil 82 may change shape as the charging head is shaped 58 .
- a change in the shape of the coil may decrease the efficiency of energy transfer from the charging head 58 to the IPG 14 .
- the charging head 58 includes one or more sensors 118 , e.g., one or more strain gauges, in communication with the coil 82 .
- the sensors 118 may monitor the shape of the coil 82 on a continuous or intermittent basis, or on a discrete basis as selectively determined by manual operation (e.g., via a communication system used by medical personnel).
- the sensors 118 then communicate the shape of the coil 82 to the processor 120 , or optionally a separate processor.
- the processor 120 then communicates directly or indirectly to the coil 82 , e.g., through the amplifier 80 and/or a separate programmer, to raise or lower the frequency of the charge delivered from the coil 82 to the IPG 14 to maintain charge efficiency based on the changed shape of the coil 82 .
- the sensors 118 determine that the coil 82 is curved a certain amount as the charging head 58 is shaped, the sensors 118 communicate the change in the shape of the coil 82 to the processor 120 .
- the processor 120 then adjusts the charging frequency of the coil 82 to a value corresponding to the changed shape of the coil 82 .
- the processor 120 may include a memory component 102 (see FIG. 4 ) with a program that correlates the shape of the coil 82 with resistance in the coil 82 and then determines the needed adjustment in the charging frequency of the coil 82 to maintain an efficient charge rate of the IPG 14 .
- Other features regarding the parts, circuitry, and operation of the sensors 118 and the processor 120 are known and understood in the art and thus, for purposes of brevity, are not included here.
- the external charger 18 may include a bar charge indicator (not shown) located on the portable charger 50 or on the charging head 58 , which provides a visual indication in the form of bars of the charging strength between the coil 82 and the IPG 14 .
- the bar charge indicator may also signal to the user whether the coil 82 is properly aligned with the IPG 14 .
- the external charger 18 may further include a misalignment indicator (not shown) located on the charging head 58 that provides an audible or tactile indication when the coil 82 is misaligned relative to the IPG 14 .
- the misalignment indicator will generate an audible or tactile indication to indicate an alignment condition only when the charging head 58 is sufficiently aligned with the IPG 14 .
- the charging head 58 may be adhered to the patient's skin as described above. Details of the bar charge indicator and misalignment indicator are disclosed in U.S. patent application Ser. No. 11/748,436, which is expressly incorporated herein by reference.
- the IPG 14 includes an antenna 84 , and in particular a coil, configured for receiving the alternating current from the external charger 18 via the inductive coupling.
- the coil 84 may be identical to, and preferably has the same resonant frequency as, the coil 82 of the external charger 18 .
- the IPG 14 further comprises rectifier circuitry 86 for converting the alternating current back to DC power.
- the rectifier circuitry 86 may, e.g., take the form of a bridge rectifier circuit.
- the IPG 14 further includes a rechargeable battery 88 , such as a Lithium Ion battery, which is charged by the DC power output by the rectifier circuitry 86 .
- charging of the IPG 14 continues until the battery of the IPG 14 has been charged to at least 80% of capacity.
- the battery 88 can be fully charged by the external charger 18 in under three hours (80% charge in two hours), at implant depths of up to 2.5 cm.
- the IPG 14 also includes: a charge controller 90 , which serves to convert the DC power from the rectifier circuitry 86 to the proper charge current and voltage for the battery 88 ; a battery protection circuit 92 , which monitors the voltage and current of the battery 88 to ensure safe operation via operation of a FET switch 94 ; and a fuse 96 that disconnects the battery 88 in response to an excessive current condition that occurs over an extended period of time. Further details discussing this control and protection circuitry are described in U.S. Pat. No. 6,516,227, which has been previously incorporated herein by reference.
- the charging head 58 encases the coil 82 that is configured for transmitting the alternating current to the IPG 14 via inductive coupling.
- the coil 82 may comprise a 36 turn, single layer, 30 AWG copper air-core coil having a typical inductance of 45 pH and a DC resistance of about 1.15 ⁇ .
- the coil 82 may be tuned for a resonance at 80 KHz with a parallel capacitor (not shown).
- the charging head 58 is formed from a flexible material that allows the charging head 58 to be selectively shaped as desired, e.g., by the user squeezing or bending the charging head 58 (see FIG. 5B ). In this manner, the charging head 58 is shaped to conform to a bodily surface of the patient.
- the material forming the charging head 58 may, e.g., be composed of silicone, rubber, polyurethane, or a combination of these and/or similar materials.
- the charging head 58 also includes a plurality of malleable support members 110 (some shown in phantom) that bend as the charging head 58 is shaped. Once the charging head 58 is shaped as desired, the support members 110 substantially maintain their bent form and thus help maintain the desired shape of the charging head 58 , as shown in FIG. 5B . In other words, the support members 110 help to hold the charging head 58 in a fixed configuration until a physical force is applied to change the shape of the charging head 58 .
- the support members 110 form longitudinal ribs. In other embodiments, the support members 110 may form plates 110 a (see FIG. 6A ) or a mesh 110 b (see FIG. 6B ). The support members 110 may extend through the length of the charging head 58 or only a portion of the charging head 58 . Also, the support members 110 may be formed of aluminum, plastic, or other suitable materials that do not impede the charging function of the external charger 18 while helping to support and maintain the shape of the charging head 58 .
- the charging head 58 may also have other structures, other than the elliptical structure shown in FIGS. 5A and 5B , which allow the charging head 58 to be bent into other shapes.
- FIG. 7A illustrates an embodiment in which the charging head 58 has legs 59 in an X-shaped configuration, wherein the legs 59 can be bent toward each other, as shown in FIG. 7B . This embodiment may be particularly useful for encircling a patient's limb.
- the charging head 58 can substantially conform to a surface of the patient, the efficiency with which the coil 82 charges the IPG 14 may be increased, as any gaps between the charger 18 and the patient's skin are minimized or eliminated. At the same time, the patient's comfort is enhanced, because the charging head 58 is shaped to suit the patient. However, as the charging head 58 is shaped, the shape of the coil 82 may change, which in turn may affect the charging efficiency of the coil 82 .
- the charging head 58 includes the sensors 118 , described above in reference to FIG. 4 , to monitor changes in the shape of the coil 82 .
- the sensors 118 may be placed over the coil 82 on one or both sides of the coil 82 , and may also be affixed to the coil 82 with a suitable connector or adhesive. While the sensors 118 are illustrated on the embodiment of the charger head 58 shown in FIGS. 5A and 5B , the sensors 118 may also be used on the other embodiments described herein.
- another embodiment of the charging head 58 is initially formed from a flexible material that allows the charging head 58 to be selectively shaped as desired, as described above.
- the flexible material can be cured afterward, by heat-setting or other processes known in the art, such that the charging head 58 remains set in the selected shape.
- This embodiment may be particularly useful when a sturdier, less flexible, i.e., more permanent, form of the charging head 58 is desired.
- the material forming the charging head 58 is substantially composed of a thermoset plastic.
- the thermoset plastic is cured using a suitable process known in the art, such as heat-setting or exposure to ultraviolet light, wherein the thermoset plastic maintains a fixed shape, as shown in FIG. 8A .
- the thermoplastic cannot be re-cured and re-shaped and thus remains in the fixed shape.
- the material forming the charging head 58 is substantially composed of a thermoplastic.
- the thermoplastic is cured using a suitable process known in the art, such as by cooling or a catalyst chemical reaction. The thermoplastic maintains a fixed shape without any additional treatment but can later be heated, or other suitable processes can be used, to return the thermoplastic to a flexible state.
- the thermoplastic can be re-shaped and re-cured to maintain a new shape as desired, which can also be done multiple times.
- FIGS. 9A-9F another embodiment of a charging head 58 includes a bendable shell 112 that can be selectively shaped.
- the shell 122 has a plurality of hinged sections 114 that pivot against each other as the shell 112 is bent in shaping the charging head 58 .
- the shell 112 may be bent from a flat configuration to a crescent configuration ( FIG. 9B ).
- the hinged sections 114 may employ any of a variety of suitable hinge mechanisms known in the art that allow the hinged sections 114 to pivot against each other while providing a wide range of movement, such as a butterfly hinge 115 a ( FIG. 9C ), a flush hinge 115 b ( FIG. 9D ), or a barrel hinge 115 c ( FIG.
- the hinge designs may also include gear teeth or other components known in the art to control the hinging movement of the hinged sections 114 and to help maintain the shell 112 in a desired shape.
- the shell 112 may be composed of any of a variety of suitable materials that are sufficiently rigid to help stabilize the shell 112 without interfering with the charging action of the external charger 18 , such as plastic, ceramic, or a combination of these and/or similar materials.
- the shell 112 may further include a skin 116 that substantially covers the outer surface of the shell 112 , as shown in FIG. 10 , or alternatively, the inner surface of the shell 112 or both the inner and outer surfaces of the shell 112 .
- the skin 116 helps to protect the coil 82 and other electrical components in the charging head 58 , such that if the shell 112 is bent enough to form an open space between the hinged sections 114 , or if the shell 112 cracks or breaks, the electrical components remain covered.
- the skin 116 is preferably composed of one or more waterproof materials that are sufficiently flexible to accommodate bending of the shell 112 , such as plastic, rubber, polyurethane, or a combination of these and/or similar materials.
- the charging head 58 and the portable charger 50 are placed in the general vicinity of the implanted IPG 14 (step 200 ), as shown in FIG. 12 .
- the portable charger 50 is turned on (step 202 ), thereby transcutaneously transmitting charging energy from the charging head 58 to the IPG 14 to charge the IPG 14 , as described above (step 204 ).
- the proper placement of the charging head 58 is then determined (step 206 ) to help optimize charging efficiency of the IPG 14 .
- audible or tactile indications from the indicator are used to determine proper alignment between the charging head 58 and the IPG 14 .
- the charging head 58 is then shaped to conform to the surface of the patient where the charging head 58 will be attached (step 208 ), as shown in FIG. 13 .
- the support members 110 help maintain the shape of the charging head 58 on the patient.
- the charging head 58 may be first shaped on the patient, after which the material is cured, and then the charging head 58 is returned for use on the patient.
- the charging head 58 is bent to conform to the patient, causing the hinged sections 114 to pivot as the charging head 58 is bent, as shown in FIG. 14 .
- the charging head 58 is then adhered to the patient (step 210 ).
- the charging head may be adhered to the patient using any suitable form of adhesive, wherein the form of adhesive is preferably comfortable for the patient.
- the charging head may include double-sided medical tape that can be added and removed as needed, or a moisture-activated adhesive patch (not shown), wherein a small amount of liquid is applied to the patch for adherence to the patient.
- the patch may be selectively placed on different areas or fixed on one area of the charging head 58 .
- opposing ends of the charging head may be joined by a suitable adhesive, for example, to secure the charging head around a patient's limb, neck, or head.
- the charging head may also be connected to a strap (not shown) that is secured to the patient by a snap, button, or hook-and-loop attachment, as examples, for additional support on the patient.
- the charging frequency of the energy may then be adjusted based on the shape of the coil 82 in the charging head 58 .
- the sensors 118 determine the shape of the coil 82 (step 212 ) and communicate any change in shape to the processor 120 (step 214 ).
- the processor 120 determines the proper charging frequency of the coil 82 to maintain charging efficiency (step 216 ) and causes the coil 82 to adjust to such frequency (step 218 ).
- the charging frequency may be adjusted based on values stored in memory 102 in the processor 120 . If further shaping or movement of the charging head 58 occurs to change the coil 82 shape, the sensors 118 will determine the new shape of the coil 82 and communicate the new shape to the processor 120 , which in turn will adjust the charging frequency of the coil 82 .
- the charging head 58 thus continues to charge the IPG 14 as needed, preferably until the IPG 14 is fully charged, after which the charging head 58 is removed from the patient (step 220 ).
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 12/495,645, filed Jun. 30, 2009, which application is expressly incorporated by reference herein.
- The present invention relates to external charging devices for implantable devices, and more particularly, to devices for transcutaneously recharging devices implanted within patients.
- Implantable stimulation devices are devices that generate and deliver electrical stimuli to body nerves and tissues for the therapy of various biological disorders, such as: pacemakers to treat cardiac arrhythmia; defibrillators to treat cardiac fibrillation; cochlear stimulators to treat deafness; retinal stimulators to treat blindness; muscle stimulators to produce coordinated limb movement; spinal cord stimulators to treat chronic pain; cortical and deep brain stimulators to treat motor and psychological disorders; and other neural stimulators to treat urinary incontinence, sleep apnea, shoulder sublaxation, etc. The present invention may find applicability in all such applications, although the description that follows will generally focus on the use of the invention within a spinal cord stimulation system, such as that disclosed in U.S. Pat. No. 6,516,227 (“the '227 patent”), issued Feb. 4, 2003 in the name of inventors Paul Meadows et al., which is incorporated herein by reference in its entirety.
- As an alternative to having a lead or wire pass through the skin of the patient, power and/or data can be supplied to an implanted medical device via an RF or electromagnetic link that couples power from an external (non-implanted) coil to an internal (implanted) coil. So long as a suitable link, e.g., an inductive link, is established between these two coils, which means some sort of external power source must be carried by or worn by the patient, power and/or data can be continuously supplied to the implanted medical device from the worn or carried external device, thereby allowing the implanted medical device to perform its intended function.
- It is also known to power an implanted medical device with a battery that is housed internal to the implanted device. However, any battery used for extended periods of time will eventually need to be either recharged or replaced. Replacing an internally implanted battery may subject the patient to further surgery and thus is not desirable, at least not on a frequent basis.
- Rather than replace an implanted battery, the battery can be recharged by transcutaneously coupling power from an external source to an implanted receiver that is connected to the battery. Although power can be coupled from an external source at radio frequencies using matching antennas, it is generally more efficient to employ an external transmission coil and an internal receiving coil which are inductively (electromagnetically) coupled to each other to transfer power at lower frequencies. In this approach, the external transmission coil is energized with alternating current (AC), producing a varying magnetic flux that passes through the patient's skin and induces a corresponding AC voltage in the internal receiving coil. The voltage induced in the receiving coil may then be rectified and used to power the implanted device and/or to charge a battery or other charge storage device (e.g., an ultracapacitor), which in turn powers the implanted device. For example, U.S. Pat. No. 4,082,097 discloses a system for charging a rechargeable battery in an implanted human tissue stimulator by means on an external power source.
- To allow for flexibility of use and increased comfort to a patient as the implanted battery is charged, the patient would benefit from a convenient unobtrusive external charging device that transmits power transcutaneously to an implanted device, wherein such external charging device is not only small and lightweight, but is also readily conformable to the patient in close proximity to the implanted device. For example, the device could be constructed such that it could be formed to any shape when needed, or the device could be constructed to be shaped in one particular form and then remain in that form for frequent use on the same area of the patient.
- In shaping such an external charging device to fit the patient, it is also important to consider the shape of the charging coil in the external charging device. In particular, if the shape of the charging coil in the external charging device changes as the external charging device is shaped to conform to the patient, the characteristics of the charge from the charging coil may change, possibly negatively impacting the coupling factor of the external charging device and the IPG and thus the efficiency of the charging action. Not only does good coupling increase the power transferred from the external charger to the implantable pulse generator, it also minimizes heating in the implantable pulse generator. This in turn reduces the power requirements of the external charger, which reduces heating of the external charger and minimizes the smaller form factor of the external charger. As such, maintaining good coupling may be achieved by monitoring any change in the shape of the coil and subsequently adjusting power requirements of the external charger.
- Thus, there remains a need for improved devices and methods for shapeable devices that conform to a surface of the patient while also ensuring that changes in the shape of the charging coil do not negatively impact the charging action of the implanted device.
- In accordance with the present invention, an external charger for an implantable medical device is provided. The external charger comprises a charging head that is selectively shapeable to conform to a surface of a patient. The external charger also comprises an alternating current (AC) charging coil housed in the body and configured for transcutaneously transmitting electrical energy to the implanted medical device, wherein the shape of the coil is changeable as the body is shaped. The external charger further comprises at least one sensor, such as a strain gauge, for determining the shape of the coil. In one embodiment, the external charger further comprises a processor configured to adjust the charge of the coil in response to receiving signals from the sensor(s) regarding changes in the shape of the coil.
- In another embodiment, a method of charging an implantable medical device with the external charger is provided, comprising placing the external charger on a surface of a patient in the general vicinity of the implantable device and transcutaneously transmitting energy from the coil to the implantable medical device.
- Additionally, the external charger is shaped to conform to the surface of the patient and adhered to the patient.
- Other and further aspects and features of the invention will be evident from reading the following detailed description of the preferred embodiments, which are intended to illustrate, not limit, the invention.
- The drawings illustrate the design and utility of preferred embodiments of the present invention, in which similar elements are referred to by common reference numerals. In order to better appreciate how the above-recited and other advantages and objects of the present inventions are obtained, a more particular description of the present inventions briefly described above will be rendered by reference to specific embodiments thereof, which are illustrated in the accompanying drawings. Understanding that these drawings depict only typical embodiments of the invention and are not therefore to be considered limiting of its scope, the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
-
FIG. 1 is plan view of one embodiment of a spinal cord stimulation (SCS) system arranged in accordance with the present inventions; -
FIG. 2 is a plan view of the SCS system ofFIG. 1 in use with a patient; -
FIG. 3 is a perspective view of an external charger used in the SCS system; -
FIG. 4 is a block diagram of the internal components of one embodiment of an external charger and implantable pulse generator used in the SCS system ofFIG. 1 ; -
FIGS. 5A and 5B are perspective views with cut-outs of one embodiment of a charging head used in the SCS system ofFIG. 1 ; -
FIGS. 6A and 6B are perspective views with cut-outs of alternative embodiments of the charging head shown inFIGS. 5A and 5B ; -
FIGS. 7A and 7B are perspective views of another alternative embodiment of the charging head shown inFIGS. 5A and 5B ; -
FIGS. 8A and 8B are perspective views of another alternative embodiment of a charging head, featuring a curable material, used in the SCS system ofFIG. 1 ; -
FIGS. 9A-9F are perspective views with cut-outs of another alternative embodiment of a charging head, featuring a plurality of hinged sections, used in the SCS system ofFIG. 1 ; -
FIG. 10 is a perspective view of an alternative embodiment of the charging head shown inFIGS. 9A-9F ; -
FIG. 11 is a flow diagram of a method used by the external charger to charge the implantable pulse generator. -
FIGS. 12 and 13 are perspective views of a method of using the external charger in the SCS system ofFIG. 1 , and in particular using the charging head illustrated inFIGS. 5A and 5B ; and -
FIG. 14 is a perspective view of a method of using the external charger in the SCS system ofFIG. 1 , and in particular using the charging head illustrated inFIGS. 8A-8F . - At the outset, it is noted that the present invention may be used with an implantable pulse generator (IPG) or similar implanted electrical stimulator, which may be used as a component of numerous different types of stimulation systems. The description that follows relates to a spinal cord stimulation (SCS) system. However, it is to be understood that the while the invention lends itself well to applications in SCS, the invention, in its broadest aspects, may not be so limited. Rather, the invention may be used with any type of implantable electrical circuitry used to stimulate tissue. For example, the present invention may be used as part of a pacemaker, a defibrillator, a cochlear stimulator, a retinal stimulator, a stimulator configured to produce coordinated limb movement, a cortical and deep brain stimulator, peripheral nerve stimulator, or in any other neural stimulator configured to treat urinary incontinence, sleep apnea, shoulder sublaxation, etc.
- Turning first to
FIG. 1 , anexemplary SCS system 10 generally comprises animplantable neurostimulation lead 12, an implantable pulse generator (IPG) 14, an external (non-implanted)programmer 16, and an external (non-implanted)charger 18. In the illustrated embodiment, thelead 12 is a percutaneous lead and, to that end, includes a plurality of in-line electrodes 20 carried on aflexible body 22. TheIPG 14 is electrically coupled to thelead 12 in order to direct electrical stimulation energy to each of theelectrodes 20. - The
IPG 14 includes an outer case formed from an electrically conductive, biocompatible material, such as titanium. The case forms a hermetically sealed compartment wherein the electronic and other components are protected from the body tissue and fluids. While a portion of the electronic components of theIPG 14 will be described in further detail below, additional details of theIPG 14, including the battery, antenna coil, and telemetry and charging circuitry, are disclosed in U.S. Pat. No. 6,516,227, which is expressly incorporated herein by reference. - As shown in
FIG. 2 , theneurostimulation lead 12 is implanted within theepidural space 26 of a patient through the use of a percutaneous needle or other convention technique, so as to be in close proximity to thespinal cord 28. Once in place, theelectrodes 20 may be used to supply stimulation energy to thespinal cord 28 or nerve roots. The preferred placement of thelead 12 is such that theelectrodes 20 are adjacent, i.e., resting upon, the nerve area to be stimulated. TheIPG 14 may be implanted in various suitable locations of the patient's body, such as in a surgically-made pocket either in the abdomen or above the buttocks. Alead extension 30 may facilitate locating theIPG 14 away from the exit point of thelead 12. - Referring back to
FIG. 1 , theIPG 14 is programmed, or controlled, through the use of theexternal programmer 16. Theexternal programmer 16 is transcutaneously coupled to theIPG 14 through a suitable communications link (represented by the arrow 32) that passes through the patient'sskin 34. Suitable links include, but are not limited to radio frequency (RF) links, inductive links, optical links, and magnetic links. For purposes of brevity, the electronic components of theexternal programmer 16 will not be described herein. Details of the external programmer, including the control circuitry, processing circuitry, and telemetry circuitry, are disclosed in U.S. Pat. No. 6,516,227, which has been previously incorporated herein by reference. - The
external charger 18 is transcutaneously coupled to theIPG 14 through a suitable link (represented by the arrow 36) that passes through the patient'sskin 34, thereby coupling power to theIPG 14 for the purpose of operating theIPG 14 or replenishing a power source, such as a rechargeable battery (e.g., a Lithium Ion battery), within theIPG 14. In the illustrated embodiment, thelink 36 is an inductive link; that is, energy from theexternal charger 18 is coupled to the battery within theIPG 14 via electromagnetic coupling. Once power is induced in the charging coil in theIPG 14, charge control circuitry within theIPG 14 provides the power charging protocol to charge the battery. - Once the
IPG 14 has been programmed, and its power source has been charged or otherwise replenished, theIPG 14 may function as programmed without theexternal programmer 16 or theexternal charger 18 being present. While theexternal programmer 16 andexternal charger 18 are described herein as two separate and distinct units, it should be appreciated that the functionality of theexternal programmer 16 andexternal charger 18 can be combined into a single unit. It should be noted that rather than an IPG, thesystem 10 may alternatively utilize an implantable receiver-stimulator (not shown) connected to lead 12. In this case, the power source, e.g., a battery, for powering the implanted receiver, as well as control circuitry to command the receiver-stimulator, will be contained in an external controller/charger inductively coupled to the receiver-stimulator via an electromagnetic link. - Referring now to
FIG. 3 , the external components of theexternal charger 18 will now be described. In this embodiment, theexternal charger 18 takes the form of a two-part system comprising aportable charger 50 and a chargingbase station 52. The chargingbase station 52 includes anAC plug 54, so that it can be easily plugged into any standard 110 volt alternating current (VAC) or 200 VAC outlet. The chargingbase station 52 further includes an AC/DC transformer 55, which provides a suitable DC voltage (e.g., 5 VDC) to the circuitry within the chargingbase station 52. - The
portable charger 50 includes ahousing 56 for containing circuitry, and in particular, the recharging circuitry and battery (not shown inFIG. 3 ), which will be discussed in further detail below. Thehousing 56 is shaped and designed in a manner that allows theportable charger 50 to be detachably inserted into the chargingbase station 52 and returned to the chargingbase station 52 between uses, thereby allowing theportable charger 50, itself, to be recharged. Thus, both theIPG 14 and theportable charger 50 are rechargeable. Theportable charger 50 may be returned to the chargingbase station 52 between uses. Also, theportable charger 50 may be carried on the patient, e.g., in a pouch strapped to the patient, or placed near the patient. - In the illustrated embodiment, the
portable charger 50 includes a charginghead 58 connected to thehousing 56 by way of a suitableflexible cable 60. For purposes of illustration, the charginghead 58 is shown in this embodiment as having a curvaceous shape and is also flexible, more details of which will be provided below. The charginghead 58 houses anantenna 82, and in particular an AC coil 82 (seeFIGS. 5A and 5B ), which will also be described in more detail below. Thecoil 82 transmits the charging energy to theIPG 14. In an alternative embodiment, theportable charger 50 does not include a separate charging head, but instead includes a single housing that contains the recharging circuitry, battery, and AC coil. - Referring to
FIG. 4 , the recharging elements of theIPG 14 andexternal charger 18 will now be described. It should be noted that the diagram ofFIG. 4 is functional only, and is not intended to be limiting. Those of skill in the art, given the descriptions presented herein, should be able to readily fashion numerous types of recharging circuits, or equivalent circuits, that carry out the functions indicated and described. - As previously discussed above, the
external charger 18 andIPG 14 are inductively coupled together through the patient's skin 34 (shown by dotted line) via the inductive link 36 (shown by wavy arrow). Theportable charger 50 includes abattery 66, which in the illustrated embodiment is a rechargeable battery, such as a Lithium Ion battery. When a recharge is needed, energy (shown by arrow 68) is coupled to thebattery 66 via the chargingbase station 52 in a conventional manner. In the illustrated embodiment, thebattery 66 is fully charged in approximately four hours. Once thebattery 66 is fully charged, it has enough energy to fully recharge the battery of theIPG 14. If theportable charger 50 is not used and left oncharger base station 52, thebattery 66 will self-discharge at a rate of about 10% per month. Alternatively, thebattery 66 may be a replaceable battery. - The
portable charger 50 also includes: acharge controller 70, which serves to convert the DC power from an AC/DC transformer 55 to the proper charge current and voltage for thebattery 66; abattery protection circuit 72, which monitors the voltage and current of thebattery 66 to ensure safe operation via operation of FET switches 74, 76; afuse 78 that disconnects thebattery 66 in response to an excessive current condition that occurs over an extended period of time; apower amplifier 80, and in particular a radio frequency (RF) amplifier, for converting the DC power from thebattery 66 to a large alternating current; and an electricalcurrent detector 108 that measures the magnitude of the electrical current input from thepower amplifier 80 into thecoil 82, and continually outputs the measured magnitudes to aprocessor 120 as the frequency of the current is varied. Further details discussing this control and protection circuitry are described in U.S. Pat. No. 6,516,227, which has been previously incorporated herein by reference. - As will be described in further detail below, the charging
head 58 is flexible so as to be selectively shaped to conform to a patient. To allow for such flexibility, thecoil 82 may change shape as the charging head is shaped 58. However, a change in the shape of the coil may decrease the efficiency of energy transfer from the charginghead 58 to theIPG 14. Thus, to monitor changes in the shape of thecoil 82, the charginghead 58 includes one ormore sensors 118, e.g., one or more strain gauges, in communication with thecoil 82. Thesensors 118 may monitor the shape of thecoil 82 on a continuous or intermittent basis, or on a discrete basis as selectively determined by manual operation (e.g., via a communication system used by medical personnel). Thesensors 118 then communicate the shape of thecoil 82 to theprocessor 120, or optionally a separate processor. Theprocessor 120 then communicates directly or indirectly to thecoil 82, e.g., through theamplifier 80 and/or a separate programmer, to raise or lower the frequency of the charge delivered from thecoil 82 to theIPG 14 to maintain charge efficiency based on the changed shape of thecoil 82. - For example, if the
sensors 118 determine that thecoil 82 is curved a certain amount as the charginghead 58 is shaped, thesensors 118 communicate the change in the shape of thecoil 82 to theprocessor 120. Theprocessor 120 then adjusts the charging frequency of thecoil 82 to a value corresponding to the changed shape of thecoil 82. To this end, theprocessor 120 may include a memory component 102 (seeFIG. 4 ) with a program that correlates the shape of thecoil 82 with resistance in thecoil 82 and then determines the needed adjustment in the charging frequency of thecoil 82 to maintain an efficient charge rate of theIPG 14. Other features regarding the parts, circuitry, and operation of thesensors 118 and theprocessor 120 are known and understood in the art and thus, for purposes of brevity, are not included here. - To further ensure efficient transfer of energy to the
IPG 14, theexternal charger 18 may include a bar charge indicator (not shown) located on theportable charger 50 or on the charginghead 58, which provides a visual indication in the form of bars of the charging strength between thecoil 82 and theIPG 14. The bar charge indicator may also signal to the user whether thecoil 82 is properly aligned with theIPG 14. Theexternal charger 18 may further include a misalignment indicator (not shown) located on the charginghead 58 that provides an audible or tactile indication when thecoil 82 is misaligned relative to theIPG 14. Alternatively, the misalignment indicator will generate an audible or tactile indication to indicate an alignment condition only when the charginghead 58 is sufficiently aligned with theIPG 14. Once proper alignment with theIPG 14 has been achieved, as indicated by the bar charge indicator or misalignment indicator, the charginghead 58 may be adhered to the patient's skin as described above. Details of the bar charge indicator and misalignment indicator are disclosed in U.S. patent application Ser. No. 11/748,436, which is expressly incorporated herein by reference. - Turning to the IPG, the
IPG 14 includes anantenna 84, and in particular a coil, configured for receiving the alternating current from theexternal charger 18 via the inductive coupling. Thecoil 84 may be identical to, and preferably has the same resonant frequency as, thecoil 82 of theexternal charger 18. TheIPG 14 further comprisesrectifier circuitry 86 for converting the alternating current back to DC power. Therectifier circuitry 86 may, e.g., take the form of a bridge rectifier circuit. TheIPG 14 further includes arechargeable battery 88, such as a Lithium Ion battery, which is charged by the DC power output by therectifier circuitry 86. Typically, charging of theIPG 14 continues until the battery of theIPG 14 has been charged to at least 80% of capacity. In the illustrated embodiment, thebattery 88 can be fully charged by theexternal charger 18 in under three hours (80% charge in two hours), at implant depths of up to 2.5 cm. - The
IPG 14 also includes: acharge controller 90, which serves to convert the DC power from therectifier circuitry 86 to the proper charge current and voltage for thebattery 88; abattery protection circuit 92, which monitors the voltage and current of thebattery 88 to ensure safe operation via operation of aFET switch 94; and afuse 96 that disconnects thebattery 88 in response to an excessive current condition that occurs over an extended period of time. Further details discussing this control and protection circuitry are described in U.S. Pat. No. 6,516,227, which has been previously incorporated herein by reference. - Referring now to
FIGS. 5A and 5B , one embodiment of the charginghead 58 will now be described. In this embodiment, the charginghead 58 encases thecoil 82 that is configured for transmitting the alternating current to theIPG 14 via inductive coupling. Thecoil 82 may comprise a 36 turn, single layer, 30 AWG copper air-core coil having a typical inductance of 45 pH and a DC resistance of about 1.15 Ω. Thecoil 82 may be tuned for a resonance at 80 KHz with a parallel capacitor (not shown). - In the illustrated embodiment, the charging
head 58 is formed from a flexible material that allows the charginghead 58 to be selectively shaped as desired, e.g., by the user squeezing or bending the charging head 58 (seeFIG. 5B ). In this manner, the charginghead 58 is shaped to conform to a bodily surface of the patient. The material forming the charginghead 58 may, e.g., be composed of silicone, rubber, polyurethane, or a combination of these and/or similar materials. - The charging
head 58 also includes a plurality of malleable support members 110 (some shown in phantom) that bend as the charginghead 58 is shaped. Once the charginghead 58 is shaped as desired, thesupport members 110 substantially maintain their bent form and thus help maintain the desired shape of the charginghead 58, as shown inFIG. 5B . In other words, thesupport members 110 help to hold the charginghead 58 in a fixed configuration until a physical force is applied to change the shape of the charginghead 58. - In the illustrated embodiment, the
support members 110 form longitudinal ribs. In other embodiments, thesupport members 110 may formplates 110 a (seeFIG. 6A ) or amesh 110b (seeFIG. 6B ). Thesupport members 110 may extend through the length of the charginghead 58 or only a portion of the charginghead 58. Also, thesupport members 110 may be formed of aluminum, plastic, or other suitable materials that do not impede the charging function of theexternal charger 18 while helping to support and maintain the shape of the charginghead 58. - The charging
head 58 may also have other structures, other than the elliptical structure shown inFIGS. 5A and 5B , which allow the charginghead 58 to be bent into other shapes. For example,FIG. 7A illustrates an embodiment in which the charginghead 58 haslegs 59 in an X-shaped configuration, wherein thelegs 59 can be bent toward each other, as shown inFIG. 7B . This embodiment may be particularly useful for encircling a patient's limb. - Because the charging
head 58 can substantially conform to a surface of the patient, the efficiency with which thecoil 82 charges theIPG 14 may be increased, as any gaps between thecharger 18 and the patient's skin are minimized or eliminated. At the same time, the patient's comfort is enhanced, because the charginghead 58 is shaped to suit the patient. However, as the charginghead 58 is shaped, the shape of thecoil 82 may change, which in turn may affect the charging efficiency of thecoil 82. - To address such changes in charging efficiency, the charging
head 58 includes thesensors 118, described above in reference toFIG. 4 , to monitor changes in the shape of thecoil 82. Thesensors 118 may be placed over thecoil 82 on one or both sides of thecoil 82, and may also be affixed to thecoil 82 with a suitable connector or adhesive. While thesensors 118 are illustrated on the embodiment of thecharger head 58 shown inFIGS. 5A and 5B , thesensors 118 may also be used on the other embodiments described herein. - Referring to
FIGS. 8A and 8B , another embodiment of the charginghead 58 is initially formed from a flexible material that allows the charginghead 58 to be selectively shaped as desired, as described above. In this case, however, the flexible material can be cured afterward, by heat-setting or other processes known in the art, such that the charginghead 58 remains set in the selected shape. This embodiment may be particularly useful when a sturdier, less flexible, i.e., more permanent, form of the charginghead 58 is desired. In one embodiment, the material forming the charginghead 58 is substantially composed of a thermoset plastic. - Once the charging
head 58 is shaped as desired, the thermoset plastic is cured using a suitable process known in the art, such as heat-setting or exposure to ultraviolet light, wherein the thermoset plastic maintains a fixed shape, as shown inFIG. 8A . In this embodiment, the thermoplastic cannot be re-cured and re-shaped and thus remains in the fixed shape. In another embodiment, the material forming the charginghead 58 is substantially composed of a thermoplastic. In this embodiment, once the charginghead 58 is shaped as desired, the thermoplastic is cured using a suitable process known in the art, such as by cooling or a catalyst chemical reaction. The thermoplastic maintains a fixed shape without any additional treatment but can later be heated, or other suitable processes can be used, to return the thermoplastic to a flexible state. Then, as shown inFIG. 8B , the thermoplastic can be re-shaped and re-cured to maintain a new shape as desired, which can also be done multiple times. - Referring to
FIGS. 9A-9F , another embodiment of a charginghead 58 includes abendable shell 112 that can be selectively shaped. The shell 122 has a plurality of hingedsections 114 that pivot against each other as theshell 112 is bent in shaping the charginghead 58. For example, theshell 112 may be bent from a flat configuration to a crescent configuration (FIG. 9B ). The hingedsections 114 may employ any of a variety of suitable hinge mechanisms known in the art that allow the hingedsections 114 to pivot against each other while providing a wide range of movement, such as abutterfly hinge 115 a (FIG. 9C ), aflush hinge 115 b (FIG. 9D ), or abarrel hinge 115 c (FIG. 9E ), or also a joint assembly such as a ball and socket joint 115 d (FIG. 9F ). The hinge designs may also include gear teeth or other components known in the art to control the hinging movement of the hingedsections 114 and to help maintain theshell 112 in a desired shape. Theshell 112 may be composed of any of a variety of suitable materials that are sufficiently rigid to help stabilize theshell 112 without interfering with the charging action of theexternal charger 18, such as plastic, ceramic, or a combination of these and/or similar materials. - As an additional feature, the
shell 112 may further include askin 116 that substantially covers the outer surface of theshell 112, as shown inFIG. 10 , or alternatively, the inner surface of theshell 112 or both the inner and outer surfaces of theshell 112. Theskin 116 helps to protect thecoil 82 and other electrical components in the charginghead 58, such that if theshell 112 is bent enough to form an open space between the hingedsections 114, or if theshell 112 cracks or breaks, the electrical components remain covered. Theskin 116 is preferably composed of one or more waterproof materials that are sufficiently flexible to accommodate bending of theshell 112, such as plastic, rubber, polyurethane, or a combination of these and/or similar materials. - Having described the structure and function of the charging system, one method of using the
external charger 18 to recharge theIPG 14 will now be described with reference toFIGS. 11-13 . First, the charginghead 58 and theportable charger 50 are placed in the general vicinity of the implanted IPG 14 (step 200), as shown inFIG. 12 . Next, theportable charger 50 is turned on (step 202), thereby transcutaneously transmitting charging energy from the charginghead 58 to theIPG 14 to charge theIPG 14, as described above (step 204). The proper placement of the charginghead 58 is then determined (step 206) to help optimize charging efficiency of theIPG 14. For example, in the embodiment including an alignment (or misalignment) indicator, audible or tactile indications from the indicator are used to determine proper alignment between the charginghead 58 and theIPG 14. The charginghead 58 is then shaped to conform to the surface of the patient where the charginghead 58 will be attached (step 208), as shown inFIG. 13 . - In this case where the charging
head 58 illustrated inFIGS. 5A and 5B is used, thesupport members 110 help maintain the shape of the charginghead 58 on the patient. For the embodiment in which the material of the charginghead 58 is cured, the charginghead 58 may be first shaped on the patient, after which the material is cured, and then the charginghead 58 is returned for use on the patient. To charge theIPG 14 using the embodiment of the charginghead 58 illustrated inFIGS. 9A and 9B , the charginghead 58 is bent to conform to the patient, causing the hingedsections 114 to pivot as the charginghead 58 is bent, as shown inFIG. 14 . - The charging
head 58 is then adhered to the patient (step 210). The charging head may be adhered to the patient using any suitable form of adhesive, wherein the form of adhesive is preferably comfortable for the patient. For example, the charging head may include double-sided medical tape that can be added and removed as needed, or a moisture-activated adhesive patch (not shown), wherein a small amount of liquid is applied to the patch for adherence to the patient. The patch may be selectively placed on different areas or fixed on one area of the charginghead 58. Also, opposing ends of the charging head may be joined by a suitable adhesive, for example, to secure the charging head around a patient's limb, neck, or head. The charging head may also be connected to a strap (not shown) that is secured to the patient by a snap, button, or hook-and-loop attachment, as examples, for additional support on the patient. - The charging frequency of the energy may then be adjusted based on the shape of the
coil 82 in the charginghead 58. In particular, thesensors 118 determine the shape of the coil 82 (step 212) and communicate any change in shape to the processor 120 (step 214). Theprocessor 120 determines the proper charging frequency of thecoil 82 to maintain charging efficiency (step 216) and causes thecoil 82 to adjust to such frequency (step 218). The charging frequency may be adjusted based on values stored inmemory 102 in theprocessor 120. If further shaping or movement of the charginghead 58 occurs to change thecoil 82 shape, thesensors 118 will determine the new shape of thecoil 82 and communicate the new shape to theprocessor 120, which in turn will adjust the charging frequency of thecoil 82. The charginghead 58 thus continues to charge theIPG 14 as needed, preferably until theIPG 14 is fully charged, after which the charginghead 58 is removed from the patient (step 220). - Although particular embodiments of the present inventions have been shown and described, it will be understood that it is not intended to limit the present inventions to the preferred embodiments, and it will be obvious to those skilled in the art that various changes and modifications may be made without departing from the spirit and scope of the present inventions. Thus, the present inventions are intended to cover alternatives, modifications, and equivalents, which may be included within the spirit and scope of the present inventions as defined by the claims.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/569,027 US8428746B2 (en) | 2009-06-30 | 2012-08-07 | Moldable charger with shape-sensing means for an implantable pulse generator |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/495,645 US8260432B2 (en) | 2009-06-30 | 2009-06-30 | Moldable charger with shape-sensing means for an implantable pulse generator |
US13/569,027 US8428746B2 (en) | 2009-06-30 | 2012-08-07 | Moldable charger with shape-sensing means for an implantable pulse generator |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/495,645 Continuation US8260432B2 (en) | 2009-06-30 | 2009-06-30 | Moldable charger with shape-sensing means for an implantable pulse generator |
Publications (2)
Publication Number | Publication Date |
---|---|
US20130046361A1 true US20130046361A1 (en) | 2013-02-21 |
US8428746B2 US8428746B2 (en) | 2013-04-23 |
Family
ID=43381580
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/495,645 Expired - Fee Related US8260432B2 (en) | 2009-06-30 | 2009-06-30 | Moldable charger with shape-sensing means for an implantable pulse generator |
US13/569,027 Expired - Fee Related US8428746B2 (en) | 2009-06-30 | 2012-08-07 | Moldable charger with shape-sensing means for an implantable pulse generator |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/495,645 Expired - Fee Related US8260432B2 (en) | 2009-06-30 | 2009-06-30 | Moldable charger with shape-sensing means for an implantable pulse generator |
Country Status (1)
Country | Link |
---|---|
US (2) | US8260432B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015148726A1 (en) * | 2014-03-26 | 2015-10-01 | Beth Israel Deaconess Medical Center, Inc. | Activation of antimicrobial agents |
US20160199557A1 (en) * | 2015-01-14 | 2016-07-14 | Minnetronix, Inc. | Distributed transformer |
US9498627B2 (en) | 2014-01-15 | 2016-11-22 | Pacesetter, Inc. | Wireless closed-loop and system to detect and treat sleep apnea |
US9855376B2 (en) | 2014-07-25 | 2018-01-02 | Minnetronix, Inc. | Power scaling |
US10149933B2 (en) | 2014-07-25 | 2018-12-11 | Minnetronix, Inc. | Coil parameters and control |
US10193395B2 (en) | 2015-04-14 | 2019-01-29 | Minnetronix, Inc. | Repeater resonator |
US10406267B2 (en) | 2015-01-16 | 2019-09-10 | Minnetronix, Inc. | Data communication in a transcutaneous energy transfer system |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100318159A1 (en) * | 2009-06-12 | 2010-12-16 | Boston Scientific Neuromodulation Corporation | Miniature remote controller for implantable medical device |
US20100331919A1 (en) * | 2009-06-30 | 2010-12-30 | Boston Scientific Neuromodulation Corporation | Moldable charger having hinged sections for charging an implantable pulse generator |
US20100331918A1 (en) * | 2009-06-30 | 2010-12-30 | Boston Scientific Neuromodulation Corporation | Moldable charger with curable material for charging an implantable pulse generator |
US9399131B2 (en) * | 2009-06-30 | 2016-07-26 | Boston Scientific Neuromodulation Corporation | Moldable charger with support members for charging an implantable pulse generator |
US9409013B2 (en) | 2009-10-20 | 2016-08-09 | Nyxoah SA | Method for controlling energy delivery as a function of degree of coupling |
US10751537B2 (en) | 2009-10-20 | 2020-08-25 | Nyxoah SA | Arced implant unit for modulation of nerves |
US9950166B2 (en) | 2009-10-20 | 2018-04-24 | Nyxoah SA | Acred implant unit for modulation of nerves |
WO2011097289A1 (en) * | 2010-02-03 | 2011-08-11 | Medtronic, Inc. | Implantable medical devices and systems having dual frequency inductive telemetry and recharge |
US8594806B2 (en) | 2010-04-30 | 2013-11-26 | Cyberonics, Inc. | Recharging and communication lead for an implantable device |
US9136728B2 (en) | 2011-04-28 | 2015-09-15 | Medtronic, Inc. | Implantable medical devices and systems having inductive telemetry and recharge on a single coil |
US8954148B2 (en) | 2011-06-28 | 2015-02-10 | Greatbatch, Ltd. | Key fob controller for an implantable neurostimulator |
US20130006330A1 (en) | 2011-06-28 | 2013-01-03 | Greatbatch, Ltd. | Dual patient controllers |
US20130197607A1 (en) | 2011-06-28 | 2013-08-01 | Greatbatch Ltd. | Dual patient controllers |
USD736383S1 (en) | 2012-11-05 | 2015-08-11 | Nevro Corporation | Implantable signal generator |
US8929986B2 (en) | 2011-11-04 | 2015-01-06 | Nevro Corporation | Medical device communication and charging assemblies for use with implantable signal generators, and associated systems and methods |
US9079043B2 (en) | 2011-11-21 | 2015-07-14 | Thoratec Corporation | Transcutaneous power transmission utilizing non-planar resonators |
US20150018728A1 (en) | 2012-01-26 | 2015-01-15 | Bluewind Medical Ltd. | Wireless neurostimulators |
US11253712B2 (en) | 2012-07-26 | 2022-02-22 | Nyxoah SA | Sleep disordered breathing treatment apparatus |
WO2014016700A2 (en) | 2012-07-26 | 2014-01-30 | Adi Mashiach | Implant sleep apnea treatment device including an antenna |
US9907967B2 (en) | 2012-07-26 | 2018-03-06 | Adi Mashiach | Transcutaneous power conveyance device |
US10052097B2 (en) | 2012-07-26 | 2018-08-21 | Nyxoah SA | Implant unit delivery tool |
US9343923B2 (en) | 2012-08-23 | 2016-05-17 | Cyberonics, Inc. | Implantable medical device with backscatter signal based communication |
US9225190B2 (en) | 2012-09-07 | 2015-12-29 | Manufacturers And Traders Trust Company | Implant current controlled battery charging based on temperature |
US9142989B2 (en) | 2012-09-07 | 2015-09-22 | Greatbatch Ltd. | Method of minimizing interruptions to implantable medical device recharging |
US9209634B2 (en) | 2012-09-07 | 2015-12-08 | Greatbatch Ltd. | Method of improving battery recharge efficiency by statistical analysis |
US9935498B2 (en) | 2012-09-25 | 2018-04-03 | Cyberonics, Inc. | Communication efficiency with an implantable medical device using a circulator and a backscatter signal |
US9861812B2 (en) | 2012-12-06 | 2018-01-09 | Blue Wind Medical Ltd. | Delivery of implantable neurostimulators |
WO2015004540A2 (en) | 2013-06-17 | 2015-01-15 | Adi Mashiach | Dynamic modification of modulation throughout a therapy period |
WO2015179177A1 (en) | 2014-05-20 | 2015-11-26 | Nevro Corporation | Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods |
US9583256B2 (en) | 2014-06-13 | 2017-02-28 | Verily Life Sciences Llc | Three-dimensional wireless charging coil |
US20160241061A1 (en) | 2015-02-17 | 2016-08-18 | Qualcomm Incorporated | Clover leaf and butterfly coil structures for flat wireless coupling profiles in wireless power transfer applications |
US10105540B2 (en) | 2015-11-09 | 2018-10-23 | Bluewind Medical Ltd. | Optimization of application of current |
US10300277B1 (en) | 2015-12-14 | 2019-05-28 | Nevro Corp. | Variable amplitude signals for neurological therapy, and associated systems and methods |
US10603501B2 (en) | 2016-06-15 | 2020-03-31 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device having at least one sense coil concentric with a charging coil for determining position |
US10342984B2 (en) | 2016-06-15 | 2019-07-09 | Boston Scientific Neuromodulation Corporation | Split coil for uniform magnetic field generation from an external charger for an implantable medical device |
US11129996B2 (en) | 2016-06-15 | 2021-09-28 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device for determining position and optimizing power transmission using resonant frequency as determined from at least one sense coil |
US11471692B2 (en) | 2016-06-15 | 2022-10-18 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device for adjusting charging power based on determined position using at least one sense coil |
US10363426B2 (en) | 2016-06-15 | 2019-07-30 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device for determining position using phase angle or a plurality of parameters as determined from at least one sense coil |
US10226637B2 (en) | 2016-06-15 | 2019-03-12 | Boston Scientific Neuromodulation Corporation | External charger for an implantable medical device having alignment and centering capabilities |
CN106139425A (en) * | 2016-08-11 | 2016-11-23 | 深圳市奥沃医学新技术发展有限公司 | A kind of multi-diaphragm collimator |
US10124178B2 (en) | 2016-11-23 | 2018-11-13 | Bluewind Medical Ltd. | Implant and delivery tool therefor |
US10632318B2 (en) | 2017-03-21 | 2020-04-28 | Boston Scientific Neuromodulation Corporation | External charger with three-axis magnetic field sensor to determine implantable medical device position |
US20180353764A1 (en) | 2017-06-13 | 2018-12-13 | Bluewind Medical Ltd. | Antenna configuration |
EP3737459A4 (en) | 2018-01-30 | 2021-10-20 | Nevro Corp. | EFFICIENT USE OF AN IMPLANTABLE PULSE GENERATOR BATTERY AND RELATED SYSTEMS AND PROCEDURES |
WO2019183126A1 (en) | 2018-03-20 | 2019-09-26 | Tc1 Llc | Mechanical gauge for estimating inductance changes in resonant power transfer systems with flexible coils for use with implanted medical devices |
DE102018206754A1 (en) * | 2018-05-02 | 2019-11-07 | Kardion Gmbh | Method and device for determining the temperature at a surface and use of the method |
US11058875B1 (en) | 2018-09-19 | 2021-07-13 | Nevro Corp. | Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods |
US11590352B2 (en) | 2019-01-29 | 2023-02-28 | Nevro Corp. | Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods |
US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4082097A (en) | 1976-05-20 | 1978-04-04 | Pacesetter Systems Inc. | Multimode recharging system for living tissue stimulators |
US4976558A (en) | 1987-11-19 | 1990-12-11 | Brother Kogyo Kabushiki Kaisha | Device for feeding recording medium in the longitudinal recording direction |
US4981141A (en) | 1989-02-15 | 1991-01-01 | Jacob Segalowitz | Wireless electrocardiographic monitoring system |
US5307818A (en) | 1989-02-15 | 1994-05-03 | Jacob Segalowitz | Wireless electrocardiographic and monitoring system and wireless electrode assemblies for same |
US5481184A (en) | 1991-12-31 | 1996-01-02 | Sarcos Group | Movement actuator/sensor systems |
JP2631261B2 (en) | 1993-02-23 | 1997-07-16 | 務 大竹 | Bioelectric signal recorder |
DE4329898A1 (en) | 1993-09-04 | 1995-04-06 | Marcus Dr Besson | Wireless medical diagnostic and monitoring device |
US5545191A (en) | 1994-05-06 | 1996-08-13 | Alfred E. Mann Foundation For Scientific Research | Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body |
US5690693A (en) | 1995-06-07 | 1997-11-25 | Sulzer Intermedics Inc. | Transcutaneous energy transmission circuit for implantable medical device |
US5702431A (en) | 1995-06-07 | 1997-12-30 | Sulzer Intermedics Inc. | Enhanced transcutaneous recharging system for battery powered implantable medical device |
US5759199A (en) | 1995-08-02 | 1998-06-02 | Pacesetter, Inc. | System and method for ambulatory monitoring and programming of an implantable medical device |
US6076016A (en) | 1995-10-19 | 2000-06-13 | Feierbach; Gary F. | Galvanic transdermal conduction communication system and method |
JP2000505323A (en) | 1996-02-14 | 2000-05-09 | ウオルター ローレンツ,サージカル インコーポレイテッド | Bone fixation device and device for inserting it |
US6051017A (en) | 1996-02-20 | 2000-04-18 | Advanced Bionics Corporation | Implantable microstimulator and systems employing the same |
US5674249A (en) | 1996-05-02 | 1997-10-07 | Incontrol, Inc. | Atrial defibrillation system having a portable communication device |
US7107103B2 (en) | 1997-02-26 | 2006-09-12 | Alfred E. Mann Foundation For Scientific Research | Full-body charger for battery-powered patient implantable device |
US5959529A (en) | 1997-03-07 | 1999-09-28 | Kail, Iv; Karl A. | Reprogrammable remote sensor monitoring system |
US6869558B2 (en) | 1997-12-18 | 2005-03-22 | Thermoplastic Composite Designs, Inc. | Thermoplastic molding process and apparatus |
US6275736B1 (en) | 1998-06-02 | 2001-08-14 | Advanced Bionics Corporation | Hair clip retention system for headpiece of cochlear implant system |
US6704602B2 (en) | 1998-07-02 | 2004-03-09 | Medtronic, Inc. | Implanted medical device/external medical instrument communication utilizing surface electrodes |
US5948006A (en) | 1998-10-14 | 1999-09-07 | Advanced Bionics Corporation | Transcutaneous transmission patch |
US6290646B1 (en) | 1999-04-16 | 2001-09-18 | Cardiocom | Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients |
US6166518A (en) | 1999-04-26 | 2000-12-26 | Exonix Corporation | Implantable power management system |
DE19929328A1 (en) | 1999-06-26 | 2001-01-04 | Daimlerchrysler Aerospace Ag | Device for long-term medical monitoring of people |
US6804558B2 (en) | 1999-07-07 | 2004-10-12 | Medtronic, Inc. | System and method of communicating between an implantable medical device and a remote computer system or health care provider |
US7177690B2 (en) | 1999-07-27 | 2007-02-13 | Advanced Bionics Corporation | Implantable system having rechargeable battery indicator |
US6516227B1 (en) | 1999-07-27 | 2003-02-04 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
US6553263B1 (en) | 1999-07-30 | 2003-04-22 | Advanced Bionics Corporation | Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries |
US6263245B1 (en) | 1999-08-12 | 2001-07-17 | Pacesetter, Inc. | System and method for portable implantable device interogation |
US7338434B1 (en) | 2002-08-21 | 2008-03-04 | Medtronic, Inc. | Method and system for organ positioning and stabilization |
US6585644B2 (en) | 2000-01-21 | 2003-07-01 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
US6895281B1 (en) | 2000-03-31 | 2005-05-17 | Cardiac Pacemakers, Inc. | Inductive coil apparatus for bio-medical telemetry |
US6441747B1 (en) | 2000-04-18 | 2002-08-27 | Motorola, Inc. | Wireless system protocol for telemetry monitoring |
US6561975B1 (en) | 2000-04-19 | 2003-05-13 | Medtronic, Inc. | Method and apparatus for communicating with medical device systems |
US6574511B2 (en) | 2000-04-21 | 2003-06-03 | Medtronic, Inc. | Passive data collection system from a fleet of medical instruments and implantable devices |
US6850803B1 (en) | 2000-06-16 | 2005-02-01 | Medtronic, Inc. | Implantable medical device with a recharging coil magnetic shield |
EP1296744A2 (en) | 2000-06-23 | 2003-04-02 | Medtronic, Inc. | Network compatible rf wireless link for medical device data management |
ES2318238T3 (en) | 2000-07-26 | 2009-05-01 | Boston Scientific Neuromodulation Corporation | STIMULATION SYSTEM |
US7024248B2 (en) | 2000-10-16 | 2006-04-04 | Remon Medical Technologies Ltd | Systems and methods for communicating with implantable devices |
US6628989B1 (en) | 2000-10-16 | 2003-09-30 | Remon Medical Technologies, Ltd. | Acoustic switch and apparatus and methods for using acoustic switches within a body |
US6738671B2 (en) | 2000-10-26 | 2004-05-18 | Medtronic, Inc. | Externally worn transceiver for use with an implantable medical device |
US6636769B2 (en) | 2000-12-18 | 2003-10-21 | Biosense, Inc. | Telemetric medical system and method |
US20020087204A1 (en) * | 2001-01-04 | 2002-07-04 | Kung Robert T. V. | Flexible transcutaneous energy transfer (TET) primary coil |
US6647298B2 (en) | 2001-06-04 | 2003-11-11 | St. Jude Medical Ab | Implantable medical device with variable incoming communication signal discrimination, and method for operating same |
US6804554B2 (en) | 2001-10-19 | 2004-10-12 | Medtronic, Inc. | Arrangement and system for enabling patient control of electrical therapies |
WO2003061335A1 (en) | 2002-01-02 | 2003-07-24 | Advanced Bionics Corporation | Wideband low-noise implantable microphone assembly |
WO2004002572A1 (en) | 2002-06-28 | 2004-01-08 | Advanced Bionics Corporation | Microstimulator having self-contained power source and bi-directional telemetry system |
US7003353B1 (en) | 2002-12-10 | 2006-02-21 | Quallion Llc | Photovoltaic powered charging apparatus for implanted rechargeable batteries |
US7020519B2 (en) | 2003-01-24 | 2006-03-28 | Gentcorp Ltd | Hybrid battery power source for implantable medical use |
US7136701B2 (en) | 2003-01-24 | 2006-11-14 | Gentcorp Ltd. | Hybrid battery power source for implantable medical use |
AU2003903839A0 (en) | 2003-07-24 | 2003-08-07 | Cochlear Limited | Battery characterisation |
US7308316B2 (en) | 2003-10-02 | 2007-12-11 | Medtronic, Inc. | Storable implantable medical device assembly allowing in package charging |
US7286881B2 (en) | 2003-10-02 | 2007-10-23 | Medtronic, Inc. | External power source having an adjustable magnetic core and method of use |
US20050075696A1 (en) | 2003-10-02 | 2005-04-07 | Medtronic, Inc. | Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device |
US8140168B2 (en) | 2003-10-02 | 2012-03-20 | Medtronic, Inc. | External power source for an implantable medical device having an adjustable carrier frequency and system and method related therefore |
US7225032B2 (en) | 2003-10-02 | 2007-05-29 | Medtronic Inc. | External power source, charger and system for an implantable medical device having thermal characteristics and method therefore |
US7286880B2 (en) | 2003-10-02 | 2007-10-23 | Medtronic, Inc. | System and method for transcutaneous energy transfer achieving high efficiency |
US8265770B2 (en) | 2003-10-02 | 2012-09-11 | Medtronic, Inc. | Driver circuitry switchable between energy transfer and telemetry for an implantable medical device |
US7392091B2 (en) | 2003-12-30 | 2008-06-24 | Cochlear Limited | Implanted antenna and radio communications link |
US7289855B2 (en) | 2004-06-09 | 2007-10-30 | Medtronic, Inc. | Implantable medical device package antenna |
ATE465776T1 (en) | 2004-07-20 | 2010-05-15 | Medtronic Inc | SWITCHED POWER WITH TELEMETRY IN AN IMPLANTABLE MEDICAL DEVICE |
US20060025828A1 (en) | 2004-07-28 | 2006-02-02 | Armstrong Randolph K | Impedance measurement for an implantable device |
CN101048897B (en) | 2004-10-29 | 2010-10-27 | 麦德托尼克公司 | Method of charging lithium-ion battery |
US7191013B1 (en) | 2004-11-08 | 2007-03-13 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Hand held device for wireless powering and interrogation of biomems sensors and actuators |
EP1835020A4 (en) | 2005-01-07 | 2011-06-15 | Universal Bio Research Co Ltd | Carrier enclosing chip, carrier treating apparatus and method of carrier treatment |
US7392092B2 (en) | 2005-02-28 | 2008-06-24 | Cardiac Pacemakers, Inc. | Method and apparatus for operating a diversity antenna system for communicating with implantable medical device |
US7406351B2 (en) | 2005-04-28 | 2008-07-29 | Medtronic, Inc. | Activity sensing for stimulator control |
WO2006121835A1 (en) | 2005-05-06 | 2006-11-16 | Medtronic, Inc. | Implantable device with heat absorption material |
US7588392B2 (en) | 2006-04-24 | 2009-09-15 | Zurn Industries, Llc | Removable grate |
US7738965B2 (en) | 2006-04-28 | 2010-06-15 | Medtronic, Inc. | Holster for charging pectorally implanted medical devices |
EP1867955A1 (en) * | 2006-06-08 | 2007-12-19 | BrainLAB AG | Calibrated medical instrument with environment sensor |
US9002445B2 (en) | 2006-07-28 | 2015-04-07 | Boston Scientific Neuromodulation Corporation | Charger with orthogonal PCB for implantable medical device |
US7979126B2 (en) | 2006-10-18 | 2011-07-12 | Boston Scientific Neuromodulation Corporation | Orientation-independent implantable pulse generator |
US20080103557A1 (en) | 2006-10-31 | 2008-05-01 | Medtronic, Inc. | Extended shelf life storable implantable medical device assembly, shipping container and method |
US20080103543A1 (en) | 2006-10-31 | 2008-05-01 | Medtronic, Inc. | Implantable medical device with titanium alloy housing |
US8010205B2 (en) | 2007-01-11 | 2011-08-30 | Boston Scientific Neuromodulation Corporation | Multiple telemetry and/or charging coil configurations for an implantable medical device system |
US7409245B1 (en) | 2007-01-30 | 2008-08-05 | Cardiac Pacemakers, Inc. | Variable antenna matching network for an implantable antenna |
US7932696B2 (en) | 2007-05-14 | 2011-04-26 | Boston Scientific Neuromodulation Corporation | Charger alignment indicator with adjustable threshold |
US7941220B2 (en) | 2007-06-07 | 2011-05-10 | Cardiac Pacemakers, Inc. | Method and apparatus for monitoring battery status of implantable medical device |
JP6121088B2 (en) * | 2007-09-06 | 2017-04-26 | スミス アンド ネフュー インコーポレイテッド | System and method for communicating with a telemetric implant |
US8626297B2 (en) | 2007-09-20 | 2014-01-07 | Boston Scientific Neuromodulation Corporation | Apparatus and methods for charging an implanted medical device power source |
WO2009042063A1 (en) | 2007-09-27 | 2009-04-02 | Cardiac Pacemakers, Inc. | Implantable lead with an electrostimulation capacitor |
US8362742B2 (en) | 2007-10-26 | 2013-01-29 | Medtronic, Inc. | Method and apparatus for dynamic adjustment of recharge parameters |
US8498716B2 (en) | 2007-11-05 | 2013-07-30 | Boston Scientific Neuromodulation Corporation | External controller for an implantable medical device system with coupleable external charging coil assembly |
US20090174206A1 (en) | 2008-01-04 | 2009-07-09 | Daniel Roger Vander Sluis | Multi-positional lid for a vehicle console |
US8751001B2 (en) * | 2008-10-23 | 2014-06-10 | Medtronic, Inc. | Universal recharging of an implantable medical device |
US9399131B2 (en) | 2009-06-30 | 2016-07-26 | Boston Scientific Neuromodulation Corporation | Moldable charger with support members for charging an implantable pulse generator |
US20100331919A1 (en) | 2009-06-30 | 2010-12-30 | Boston Scientific Neuromodulation Corporation | Moldable charger having hinged sections for charging an implantable pulse generator |
US20100331918A1 (en) | 2009-06-30 | 2010-12-30 | Boston Scientific Neuromodulation Corporation | Moldable charger with curable material for charging an implantable pulse generator |
-
2009
- 2009-06-30 US US12/495,645 patent/US8260432B2/en not_active Expired - Fee Related
-
2012
- 2012-08-07 US US13/569,027 patent/US8428746B2/en not_active Expired - Fee Related
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9498627B2 (en) | 2014-01-15 | 2016-11-22 | Pacesetter, Inc. | Wireless closed-loop and system to detect and treat sleep apnea |
WO2015148726A1 (en) * | 2014-03-26 | 2015-10-01 | Beth Israel Deaconess Medical Center, Inc. | Activation of antimicrobial agents |
US10220119B2 (en) | 2014-03-26 | 2019-03-05 | Beth Israel Deaconess Medical Center, Inc. | Activation of antimicrobial agents |
US9855376B2 (en) | 2014-07-25 | 2018-01-02 | Minnetronix, Inc. | Power scaling |
US10149933B2 (en) | 2014-07-25 | 2018-12-11 | Minnetronix, Inc. | Coil parameters and control |
US10376625B2 (en) | 2014-07-25 | 2019-08-13 | Minnetronix, Inc. | Power scaling |
US10898628B2 (en) | 2014-07-25 | 2021-01-26 | Minnetronix, Inc. | Coil parameters and control |
US20160199557A1 (en) * | 2015-01-14 | 2016-07-14 | Minnetronix, Inc. | Distributed transformer |
US10342908B2 (en) * | 2015-01-14 | 2019-07-09 | Minnetronix, Inc. | Distributed transformer |
US11207516B2 (en) | 2015-01-14 | 2021-12-28 | Minnetronix, Inc. | Distributed transformer |
US10406267B2 (en) | 2015-01-16 | 2019-09-10 | Minnetronix, Inc. | Data communication in a transcutaneous energy transfer system |
US11235141B2 (en) | 2015-01-16 | 2022-02-01 | Minnetronix, Inc. | Data communication in a transcutaneous energy transfer system |
US10193395B2 (en) | 2015-04-14 | 2019-01-29 | Minnetronix, Inc. | Repeater resonator |
US11894695B2 (en) | 2015-04-14 | 2024-02-06 | Minnetronix, Inc. | Repeater resonator |
Also Published As
Publication number | Publication date |
---|---|
US20100331920A1 (en) | 2010-12-30 |
US8260432B2 (en) | 2012-09-04 |
US8428746B2 (en) | 2013-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8428746B2 (en) | Moldable charger with shape-sensing means for an implantable pulse generator | |
US9399131B2 (en) | Moldable charger with support members for charging an implantable pulse generator | |
US20100331919A1 (en) | Moldable charger having hinged sections for charging an implantable pulse generator | |
US20100331918A1 (en) | Moldable charger with curable material for charging an implantable pulse generator | |
US9407110B2 (en) | Self-affixing external charging system for an implantable medical device | |
US8044635B2 (en) | Charger alignment indicator with adjustable threshold | |
US20100010582A1 (en) | Medical system and method for setting programmable heat limits | |
US8175717B2 (en) | Ultracapacitor powered implantable pulse generator with dedicated power supply | |
US10010717B2 (en) | External charger with adjustable alignment indicator | |
AU2012355904B2 (en) | A system for an implantable medical device having an external charger coupleable to accessory charging coils | |
US20120012630A1 (en) | Charger belt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20210423 |